you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Mar 05, 16:00
4489.40 -84.90 (-1.86%)
Volume
AVERAGE VOLUME
5-Day
49,304
10-Day
90,658
30-Day
73,817
29,961
  • Prev. Close

    4574.30

  • Open Price

    4548.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Mar 05, 15:59
4492.50 -82.55 (-1.80%)
Volume
AVERAGE VOLUME
5-Day
1,275,449
10-Day
1,255,647
30-Day
1,423,611
826,369
  • Prev. Close

    4575.05

  • Open Price

    4550.00

  • Bid Price (Qty.)

    4492.50 (759)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 2,775.80 1,700.70 697.00 1,544.50 1,580.00  
Net CashFlow From Operating Activities 1,839.20 2,762.10 1,538.60 1,015.90 2,798.20  
Net Cash Used In Investing Activities -1,689.20 -550.90 -1,179.90 1,442.50 -1,961.10  
Net Cash Used From Financing Activities -224.10 -2,223.10 -304.40 -2,581.80 -693.70  
Foreign Exchange Gains / Losses 0.00 4.40 -0.30 -12.00 -9.20  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -74.10 -7.50 54.00 -135.40 134.20  
Cash And Cash Equivalents Begin of Year 113.20 120.70 66.70 202.10 60.00  
Cash And Cash Equivalents End Of Year 39.10 113.20 120.70 66.70 194.20  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs